Princeton, NJCIK 19078844 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
35 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Cogent Biosciences Inc | 6.17M | $218.99M | 14.3% | −1.72M | Reduced |
| 2 | Vera Therapeutics Inc | 3.43M | $173.85M | 11.3% | −594.7K | Reduced |
| 3 | Syndax Pharmaceuticals Inc | 8.05M | $169.15M | 11.0% | −469.0K | Reduced |
| 4 |
| 5.94M |
| $161.42M |
| 10.5% |
| −157.5K |
| Reduced |
| 5 | Vaxcyte Inc | 2.92M | $134.84M | 8.8% | −149.3K | Reduced |
| 6 | Biocryst Pharmaceuticals Inc | 9.37M | $73.06M | 4.8% | −23.7K | Reduced |
| 7 | Beam Therapeutics Inc | 2.44M | $67.64M | 4.4% | −77.4K | Reduced |
| 8 | Viridian Therapeutics Inc | 1.47M | $45.76M | 3.0% | −2.96M | Reduced |
| 9 | Tyra Biosciences Inc | 1.56M | $41.13M | 2.7% | −765.5K | Reduced |
| 10 | Cg Oncology Inc | 945.8K | $39.27M | 2.6% | −1.06M | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio